---
title: "諾和諾德旗下 Ozempic 獲歐盟推薦使用以治療動脈疾病"
description: "諾和諾德週一宣佈，歐洲委員會建議使用其 2 型糖尿病和減肥胖藥物 Ozempic，用以針對外周動脈疾病 (PAD) 以及其主要治療問題。該公司表示，預計歐洲委員會將在約兩個月內更新該藥物的標籤。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/245769409.md"
published_at: "2025-06-23T20:22:59.000Z"
---

# 諾和諾德旗下 Ozempic 獲歐盟推薦使用以治療動脈疾病

> 諾和諾德週一宣佈，歐洲委員會建議使用其 2 型糖尿病和減肥胖藥物 Ozempic，用以針對外周動脈疾病 (PAD) 以及其主要治療問題。該公司表示，預計歐洲委員會將在約兩個月內更新該藥物的標籤。

諾和諾德 (NVO.US) 週一宣佈，歐洲委員會建議使用其 2 型糖尿病和減肥胖藥物 Ozempic，用以針對外周動脈疾病 (PAD) 以及其主要治療問題。

該公司表示，預計歐洲委員會將在約兩個月內更新該藥物的標籤。

### Related Stocks

- [NVO.US - 諾和諾德公司](https://longbridge.com/zh-HK/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| US sugar industry weighs impact from new dietary guidelines regulation | The U.S. sugar industry is facing potential impacts from new dietary guidelines that may reduce domestic sugar demand. S | [Link](https://longbridge.com/zh-HK/news/276479104.md) |
| As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? | [Link](https://longbridge.com/zh-HK/news/270794581.md) |
| Cruise operator Carnival to unify dual listing | Carnivalannounced plans to unify its dual listings in New York and London and redomicile to Bermuda. The UK-listed Carni | [Link](https://longbridge.com/zh-HK/news/276491689.md) |
| Tempus AI EVP Erik Phelps Sells Shares | Erik Phelps, EVP and Chief Admin. Officer of Tempus AI, sold 9,464 shares of Class A Common Stock on February 19, 2026,  | [Link](https://longbridge.com/zh-HK/news/276495655.md) |
| Annette Franqui Purchases 1,540 Shares of OFG Bancorp (NYSE:OFG) Stock | OFG Bancorp Director Annette Franqui purchased 1,540 shares of the company's stock at $42.06 per share, totaling $64,772 | [Link](https://longbridge.com/zh-HK/news/276494822.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。